findmyKOL
Clinical trialNCT04325776UnknownPhase 2Interventional

A Study of AL2846 Versus Zoledronic Acid in Subjects With Advanced Non-Small Cell Lung Cancer With Bone Metastasis

SponsorChia Tai Tianqing Pharmaceutical Group Co., Ltd.Enrollment60Bone Metastatic Non-small Cell Lung Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China
  • Anhui Chest Hospital

    Hefei, Anhui, China

    Xuhong Min, Doctor
    Recruiting
  • Henan Cancer Hospital

    Zhengzhou, Henan, China

    Suxia Luo, Doctor
    Recruiting
  • China-Japan Union Hospital of Jilin University

    Changchun, Jilin, China

    Yuansong Bai, Master
    Not, yet, recruiting
  • Jinzhou Central Hospital

    Jinzhou, Liaoning, China

    Wei Wang, Master
    Recruiting
  • Shenyang Chest Hospital

    Shenyang, Liaoning, China

    Yinyin Li, Doctor
    Recruiting
  • Sir Run Run Shaw Hospital (srrsh)

    Hangzhou, Zhejiang, China

    Hongming Pan, Doctor
    Recruiting
  • the First Hospital of Jiaxing

    Jiaxing, Zhejiang, China

    Xinmei Yang, Master
    Not, yet, recruiting
  • Quzhou People'S Hospital

    Quzhou, Zhejiang, China

    Qinhong Zheng, Master
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
24 Sept 2020
Primary completion
31 May 2021
Completion
30 Nov 2021
Last update posted
12 Oct 2020
Registered enrollment
60
Registry id
NCT04325776

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.